-
Signature
-
/s/ Lubna R. Malik, Attorney-in-Fact for Mr. Harvey
-
Issuer symbol
-
GM
-
Transactions as of
-
05 Aug 2025
-
Net transactions value
-
-$1,037,040
-
Form type
-
4
-
Filing time
-
07 Aug 2025, 16:53:07 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Harvey Rory |
Executive Vice President |
300 RENAISSANCE CENTER, M/C: 482-C24-A68, DETROIT |
/s/ Lubna R. Malik, Attorney-in-Fact for Mr. Harvey |
07 Aug 2025 |
0001976795 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
GM |
Common Stock |
Sale |
$607,635 |
-11,454 |
-43% |
$53.05 |
15,384 |
05 Aug 2025 |
Direct |
F1 |
| transaction |
GM |
Common Stock |
Sale |
$362,033 |
-6,871 |
-45% |
$52.69 |
8,513 |
05 Aug 2025 |
Direct |
F2 |
| transaction |
GM |
Common Stock |
Options Exercise |
$233,993 |
+5,652 |
+66% |
$41.40 |
14,165 |
05 Aug 2025 |
Direct |
|
| transaction |
GM |
Common Stock |
Sale |
$301,365 |
-5,652 |
-40% |
$53.32 |
8,513 |
05 Aug 2025 |
Direct |
|
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
GM |
Employee Stock Option (Right to Buy) |
Options Exercise |
$0 |
-5,652 |
-50% |
$0.000000 |
5,652 |
05 Aug 2025 |
Common Stock |
5,652 |
$41.40 |
Direct |
F3 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: